Soleno Therapeutics, Inc. SLNO
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Derek Archila | Wells Fargo | 63.85 $ | 106 $ | 42.15 % | 05/11/2025 |
| Brian Skorney | Robert W. Baird | 81.57 $ | 121 $ | 39.43 % | 11/07/2025 |
| Debjit Chattopadhyay | Guggenheim | 70.22 $ | 81 $ | 10.78 % | 28/03/2025 |
| Raghuram Selvaraju | H.C. Wainwright | 50.905 $ | 70 $ | 19.10 % | 02/12/2024 |
| Dae Gon Ha | Stifel Nicolaus | 50.49 $ | 74 $ | 23.51 % | 01/10/2024 |
| Dae Gon | Stifel Nicolaus | 49.04 $ | 59 $ | 9.96 % | 27/08/2024 |
| Leland Gershell | Oppenheimer | 46.76 $ | 65 $ | 18.24 % | 27/08/2024 |
| Yasmeen Rahimi | Piper Sandler | 42.42 $ | 93 $ | 50.58 % | 23/05/2024 |
| Brian Skorney | Robert W. Baird | 47.64 $ | 72 $ | 24.36 % | 09/05/2024 |